Veeva Systems

Veeva Systems

VEEV
Barcelona, Spain· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

VEEV · Stock Price

USD 168.25-15.82 (-8.59%)
Market Cap: $27.0B

Historical price data

Overview

Veeva Systems has established itself as the essential industry cloud platform for life sciences, serving over 1,000 organizations with a unified suite that breaks down functional silos. Its strategy centers on deep vertical expertise, a unified data model, and a commitment to its PBC charter, driving efficiency from clinical trials to commercial launch. With a market valuation of ~$29B and a dominant position in core operational software, Veeva is leveraging AI and platform expansion to solidify its infrastructure role in a rapidly digitizing industry.

Digital HealthAI / Machine Learning

Technology Platform

Veeva Vault, a unified cloud-native platform built exclusively for life sciences, integrating data, content, and process management across clinical, regulatory, quality, safety, and commercial functions.

Opportunities

The primary opportunities are the consolidation of legacy point solutions onto Veeva's unified platform and the monetization of AI-driven productivity gains through new agents and services.
Expansion into adjacent data markets and deeper penetration in emerging biotechs also present significant growth vectors.

Risk Factors

Key risks include concentration in the cyclical life sciences sector, potential competitive encroachment from large horizontal software vendors, and execution risks associated with integrating new technologies and acquisitions while maintaining growth rates.

Competitive Landscape

Veeva competes in a fragmented landscape against best-of-breed specialists (e.g., Medidata in clinical) and horizontal platforms (e.g., Salesforce in CRM). Its core advantage is its unified, industry-specific platform and data model, which reduces complexity and total cost of ownership for customers.